Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RSG | NU |
|---|---|---|
| Price | $213.63 | $13.50 |
| Change today | ▲ 0.25% | ▼ 0.88% |
| Market cap | $65.41B | $65.21B |
| Return, 3 months | +0.3% | +8.3% |
| Return, year to date | +1.7% | -19.4% |
| Return, 1 year | -5.0% | -15.7% |
| P/E (TTM) | 30.3 | 18.4 |
| P/B | 5.4 | 4.9 |
| P/E percentile vs own 5y | 38th | 36th |
| Dividend yield | 1.17% | – |
| Revenue growth (YoY, latest qtr) | +4.6% | +50.2% |
| Net profit growth (YoY) | +2.9% | +66.6% |
| Gross margin | 42.0% | – |
| Operating margin | 20.0% | – |
| Net margin | 12.9% | 27.4% |
| Return on equity | 18.2% | 31.6% |
| Analyst target vs. price | +15.2% | +33.6% |
| Analyst buy share | 56% | 75% |
| RSI (14) | 41 | 45 |
| 30-day volatility | 15.1% | 45.3% |
| Max drawdown, 1 year | -14.6% | -38.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.